FEATURES
Megan Boxall seeks the star drugs of the next decade as she examines exactly what’s in pharmaceutical company pipelines.
Get to grips with grocery retail
Philip Oakley examines the financial performance of the major supermarkets to see what the future might bring.
Understanding investment in 50 objects: Money, money, money
Three objects that illustrate the advantages, shortcomings and dangers of monetary policy, argues Philip Ryland.
A simple asset allocation strategy has generated returns in excess of 10 per cent. James Norrington decides to make some adjustments.
SEVEN DAYS
Our take on the biggest business news of the past week
NEWS
Capital concerns stalk Deutsche – will RBS be next?
Drinks makers anger over proposed sugar levy flares
Could Redx’s new antibiotic be antidote to resistance?
Investors say cheers to £79bn SAB/ABI deal
News Spotlight – Will National Grid be able to maintain its income status?
Economic Outlook – Uses of macroeconomics, Next week’s economics
COMMENT
The Editor – Defining growth
Simon Thompson – Bang on the money
Chris Dillow - On early retirement, Investing against incompetence
Mr Bearbull – The Mitie misnomer
The Trader – Mary, Mary quite contrary
Chronic Investor – A 10 per cent pay rise? That’ll do nicely.
MONEY
Top considerations when writing a will
Lifetime Isa to award bonus on monthly basis
Portfolio Clinic – Don’t take big bets on individual shares
TIPS
John Laing to tap infrastructure
Safer, securer income from Assura
Profit in all market conditions with Liontrust Special Situations
Tips Updates
FUNDS
Tracker sales to rise – but now may not be the time to buy
Big Theme – Emerging market funds for bulls and bears
SHARES
Taking Stock – Turning on the taps
Sector Focus – It’s specialise or splutter for information providers
Stock Screens – Pile into EM’s, Asia and tech trusts
Results
DIRECTORS DEALINGS